Renal dosage adjustment guidelines for antimicrobials. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 1 month after your last dose. Each 20 ml, single dose, glass vial contains 50 mg decitabine, 68 mg. This is not a complete list of side effects and others may occur. Renal drug handbook 3rd edition general intensive care unit. Thus at optimal doses, decitabine blocks this type of methylation and has an. This 3day treatment is usually repeated every 6 weeks at least 4 times. To our knowledge, the feasibility of therapy with hypomethylating agents has in patients with renal insufficiency ri has not been examined.
Decitabine injection is used to treat myelodysplastic syndromes, a group of cancers in which immature blood cells in the bone marrow do not mature and do not become healthy blood cells. Mar 06, 2020 dacogen decitabine for injection contains decitabine 5aza2deoxycitidine, an analogue of the natural nucleoside 2deoxycytidine. Listing a study does not mean it has been evaluated by the u. If your institution subscribes to this resource, and you dont have a myaccess profile, please contact your librarys reference desk for information on how to. This medication is given by injection into a vein by a health care professional in a hospital or infusion clinic the dosage is based on your medical condition, body size. Although no dose adjustment is recommended in patients with renal failure. Treatment of myelodysplastic syndrome and acute myeloid. The renal drug handbook third edition edited by caroline ashley and aileen currie uk renal pharmacy group foreword by. Jul 17, 2009 escalation study to determine bioavailability of a single oral dose of decitabine in patients with myelodysplastic syndrome mds the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Administer dacogen at a dose of 15 mgm 2 by continuous intravenous infusion over 3 hours repeated every 8 hours for 3 days.
Decitabine may also be used for purposes not listed in this medication guide. Dacogen decitabine dose, indications, adverse effects. Dosing andor duration may be adjusted according to adverse effects that may occur. Decitabine dosing schedules md anderson cancer center. For those drugs in which renal excretion is an important determinant of elimination of the intact drug or an active metabolite, dose adjustment is often required if renal function is impaired. Abacavir abacavir lamivudine abacavir lamivudine zidovudine acarbose acebutolol acetaminophen acetazolamide acetohexamide acetohydroxamic acid acetylsalicylic acid aspirin acrivastine acyclovir adefovir adenosine albuterol inhaled albuterol oral alfentanil alfentanil allopurinol alprazolam alteplase tissuetype plasminogen activator. Side effects of dacogen decitabine injection, warnings, uses.
Action inhibits dna methyltransferase, causing apoptosis. Definition from the nci drug dictionary detailed scientific definition and other names for this drug. Administer dacogen at a dose of 20 mgm repeat cycle every 4 weeks. Two approved dosage regimens are recommended for a minimum of 4 treatment cycles. Thus, all patients received the same 100 mgm2 total decitabine dose in each. This medicine is available only with your doctors prescription.
General renal dosing guidelines agents not listed below click here for a specialized list of other renal medication dosing not listed in the alphabetical main section simple renal dosing guidelines. Dacogen is supplied as a a sterile lyophilized white to almost white powder, for reconstitution in sterile water and dilution for intravenous injection. If your institution subscribes to this resource, and you dont have a myaccess profile, please contact your librarys reference desk for information on how to gain access to this resource from offcampus. Dailymed decitabine injection, powder, lyophilized, for. Pediatric drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in psychiatry. For patients with preexisting renal or hepatic impairment, consider the potential risks and benefits before initiating treatment with dacogen. Decitabine was approved by the fda for the treatment of myelodysplastic syndromes in 2006. Decitabine is an anticancer antineoplastic or cytotoxic chemotherapy drug. Decitabine is a fine, white to almost white powder with the molecular formula of c 8 h 12 n 4 o 4 and a molecular weight of 228. New drug toxicities in the onconephrology world kidney. Official title a phase 2 study of decitabine in combination with midostaurin pkc412 for elderly patients with newly diagnosed flt3itdtkd positive acute myeloid leukemia. The need for dose adjustment in patients with renal impairment has not been evaluated see section 4.
A healthcare provider will give you this injection. The optimal dosing schedule for decitabine is still unclear. For more detail, see how decitabine works section below. This guide succeeds at providing busy healthcare providers with updated and evidencebased information on dosing and monitoring commonly used medications in patients with renal dysfunction. Decitabine is soluble in dimethyl sulphoxide and sparingly soluble in water. Both drugs were first synthesized in czechoslovakia as potential chemotherapeutic agents for cancer. Highlights of prescribing information these highlights do not. Patients randomized to the decitabine for injection arm received decitabine for injection intravenously infused at a dose of 15 mgm 2 over a 3hour period, every 8 hours, for 3 consecutive days. Decitabine is used to treat myelodysplastic syndromes certain types of blood or bone. Successful treatment with lowdose decitabine in acute.
Some clinicians prefer decitabine because it is given intravenously over acute myeloid leukemia. However, decitabine shows promising clinical activity and good tolerance with the lower dosing schedules. The drugs which are in bold, details of dose reductions are mentioned below table, scroll down. Decitabine also has activity in the treatment of acute myeloid leukemia in patients aged over 60 years 24 c. The clinical trials on this list are studying decitabine.
Decitabine is in a class of medications called hypomethylation agents. For oncedaily dosing, draw a single random level 8 to 12 hours after dose given adjustments are made based on a published hartford nomogram. Miralax polyethylene glycol 3350 dose, indications, adverse. Find patient medical information for decitabine intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Escalation study to determine bioavailability of a single. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Our dacogen decitabine for injection side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this. This new book addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction.
Decitabine for injection contains decitabine 5aza2deoxycitidine, an analogue of the natural nucleoside 2deoxycytidine. Low dose decitabine, low dose azacitidine, or standard. Medlineplus information on decitabine a lay language summary of important information about this drug that may include the. The incidence of acute myelogenous leukemia aml in patients over 80 years old is 20 times greater than that observed in younger patients. Decitabine trade name dacogen, or 5aza2deoxycytidine, acts as an nucleic acid synthesis. The information on dosage adjustments in renal impairment given in this book is based on cockcroftgault creatinine clearance and not egfr, since the majority. Decitabine definition of decitabine by medical dictionary. You may be given other medications to prevent nausea or vomiting while you are receiving decitabine.
Fda approves fiveday dosing regimen for dacogen r decitabine for injection, offering a new outpatient dosing option for myelodysplastic syndromes mds news provided by eisai inc. Azacitidine and its deoxy derivative, decitabine also known as 5aza2. Clinical trials look at new ways to prevent, detect, or treat disease. Clinical trials using decitabine national cancer institute. Decitabine and midostaurin in treating older patients with. The renal drug handbook the st georges hospital, adult critical. Decitabine is available as lyophilized powder in a single dose vial, 50 mgvial.
At high doses decitabine is cytotoxic, while lower doses are associated with demethylating activity. Dosing andor duration may be adjusted according to adverse effects that. While the advice and information in this book are believed to be true and accurate at the date of publication, neither. Aml outcomes with decitabine not dependent on dosing schedule san diego, californiaolder patients with newly diagnosed acute myeloid leukemia aml had similar outcomes and early mortality regardless of whether they received decitabine in a 5 or 10day schedule, results from a recent study by nicholas j. Decitabine is classified as an antimetabolite and a demethylation agent. March 15, 2010 the us food and drug administration fda has approved a 5day dosing regimen for decitabine dacogen, eisai, inc for injection in the treatment of patients with. Aml outcomes with decitabine not dependent on dosing. Nevertheless, this is clearly an area of flux in the era of novel therapies for hcv. Hold decitabine therapy until nephrotoxicity resolves in patients who develop renal impairment i. Decitabine trade name dacogen, or 5aza2deoxycytidine, acts as an nucleic acid synthesis inhibitor.
Renal dosage adjustment guidelines for antimicrobials the pharmacists will automatically adjust the doses of any of the antimicrobials included in the protocol according to the estimated creatinine clearance generally using the cockroftgault equation for patients. Jul 01, 2005 decitabine dosing schedules decitabine dosing schedules kantarjian, hagop m issa, jeanpierre j. In renal impairment and patients on chronic haemodialysis, dose adjustment is. Drug dosing adjustments in patients with chronic kidney disease myrna y. Decitabine is used in treatment of myelodysplastic syndrome mds. The renal drug handbook 5th edition medicina interna. Fda approves 5day dosing regimen for decitabine in. Herein, we report the first use of decitabine in a patient on hemodialysis. Phase i, dose escalation study of decitabine full text view. Decitabine side effects, dosage, interactions drugs. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Get the latest treatment regimens for acute myeloid leukemia aml, such as induction therapy, consolidation therapy, and more. Decitabine is a prodrug that has to be converted into a nucleoside triphosphate to become an active drug.
Recommended initial dosing is 15 mgm2 via continuous 3hour intravenous infusion, once every 8 hours for 3 days. The total body clearance 27 mean sd was 124 19 lhrm2, and the terminal phase elimination halflife was 0. Recovery requiring more than 8, but less than 10 weeks perform bone marrow aspirate to assess for disease. Previously, no standard treatment protocol for elderly patients with aml existed, however the development of hypomethylating agents, including decitabine, has brought about promising results in aml. Xeloda capecitabine dosing, indications, interactions. Dacogen decitabine dosing, indications, interactions, adverse. Decitabine is used to treat myelodysplastic syndromes certain types of blood or bone marrow cancer.
Decitabine is eliminated by cytidine deaminase which is found intracellularly in. In patients with chronic kidney disease, batty and colleagues reported the first case series. Azacitidine, decitabine, myelodysplastic syndrome, serum creatinine. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020, wolters kluwer updated. Decitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. This information sparked further clinical trials using a lower dosing schedule since the original studies using higher doses were associated with significant myelosuppression and induction toxicity. Mar 06, 2020 decitabine is a white to off white coloured powder with the molecular formula of c 8 h 12 n 4 o 4 and a molecular weight of 228. A pilot study suggested decitabine could potentially activate gamma globin gene management of primary myelofibrosis view in chinese while the remainder received nonintensive chemotherapy eg, low dose cytarabine, azacitidine, decitabine or supportive care. Patients with renal or severe hepatic impairment treatment with dacogen has not been studied in patients with preexisting renal or hepatic impairment. Decitabine is also being studied in the treatment of other conditions and types of cancer. The use of decitabine in patients with renal disease has not been studied. Mar 06, 2020 our dacogen decitabine for injection side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication. Measure dosage with the calibrated cap provided with the bulk product, or, open the 17gram packet if packet dosing is appropriate.
Bennetts drug prescribing in renal failure has been the best pocket book for drug prescribing in patients with renal insufficiency and dialysis since the first edition in 1987. Guidelines for chemotherapy dosage adjustment hematology. Feasibility of therapy with hypomethylating agents in patients with. Decitabine for acute myeloid leukemia in a patient undergoing. Medscape myelodysplastic syndromes dosing for dacogen decitabine, frequencybased adverse effects. It works by helping the bone marrow produce normal blood cells and by killing. In initial phase i testing, the maximum tolerated dose was 15002250 mgm 2, which caused prolonged myelosuppression. Feb 10, 2020 recovery requiring more than 6, but less than 8 weeks delay decitabine for injection dosing for up to 2 weeks and reduce the dose temporarily to 11 mgm 2 every 8 hours 33 mgm 2 day, 99 mgm 2 cycle upon restarting therapy. May 10, 20 decitabine plasma pharmacokinetics remained unchanged upon repeated dosing and even from cycle to cycle.
If you are a woman, do not use decitabine if you are pregnant. Feasibility of therapy with hypomethylating agents in. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia aml. Severe renal insufficiency was defined as an estimated gfr. Derythropentofuranosyl1,3,5triazin21 hone and it has the following structural formula. Nov 14, 2018 provides accurate and independent information on more than 24,000 prescription drugs, overthecounter medicines and natural products. For hd, draw trough prehd, and peak 30 min after end of each infusion streptococci, streptococcus bovis, strep. Decitabine dosing schedules, seminars in hematology 10.
D indications treatment of various myelodysplastic syndromes mds. Clinical trials are research studies that involve people. In most cases, a decitabine injection is given every 8 hours for 3 days. Munar, pharmd, bcps, and harleen singh, pharmd oregon state university college of pharmacy, portland, oregon. Median of simplified costeffectiveness ratio was 0. For renally excreted drugs with a narrow therapeutic index, the total daily maintenance dose may be reduced either by decreasing the dose or by increasing the dosing interval, or sometimes by a combination of both. This cycle was repeated every 6 weeks, depending on the patients clinical response and toxicity. Therapeutic effects improved hematologic and clinical. Dacogen decitabine for injection is a white to almost white sterile lyophilized powder supplied in a clear colorless glass vial. Providing clinical nephrology services to patients in the louisville metro area including daily outpatient services in the kidney disease program office.
For elderly patients with aml, decitabine and lowdose cytarabine should be chosen based on the patients choice and affordability. Drug dosing adjustments in patients with chronic kidney. This phase 2 study evaluates the sequential combination of decitabine then midostaurin for the treatment of newlydiagnosed acute myeloid leukemia aml in older patients. In the absence of progression, delay decitabine for injection dosing for up to 2 more weeks and reduce the dose to 11 mgm 2 every 8 hours 33 mgm 2 day, 99 mgm 2 cycle upon restarting therapy, then maintain or increase dose in subsequent cycles as clinically indicated. Although the prevalence of an elevated serum creatinine is low in cancer patients renal dose adjustments of chemotherapy drugs. How i treat acute myeloid leukemia presenting with preexisting. Each 20 ml, single dose, glass vial contains 50 mg decitabine, 68 mg monobasic potassium phosphate potassium dihydrogen phosphate and 11. All trials on the list are supported by nci ncis basic information about clinical trials explains the types and phases of trials and how they are carried out. Nov 09, 2018 decitabine is a cancer medication that interferes with the growth and spread of cancer cells in the body. Emtriva, emtricitabine dosing, indications, interactions. A catalogue record for this book is available from the british library. Decitabine can harm an unborn baby or cause birth defects if the mother or the father is using this medicine.
The fifth edition of 2007 has been significantly expanded by dosage tables for children. Oct 15, 2014 phase i, dose escalation study of decitabine the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. The starting dose of decitabine is 20 mgm 2 by iv into the vein infusion over 1 hour repeated daily for 5 days. Dacogen, mgi pharma, inc, bloomington, mn is a cytidine analog that inhibits dna methyltransferases resulting in loss of dna methylation with subsequent gene reexpression. Dosing guidelines for varying degrees of renal impairment are stated accordingly. Polyethylene glycol 3350 powder for oral solution can be administered at any time of day. Indications and dose treatment of newly diagnosed acute myeloid leukaemia in patients over 65 years of age who are not candidates for standard induction chemotherapy. Dacogen decitabine dosing, indications, interactions. Decitabine is used to treat myelodysplastic syndrome a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells. Decitabine compared with lowdose cytarabine for the.
232 397 1123 939 182 894 1198 1407 304 1028 977 905 1457 391 1558 123 1226 1085 1450 353 405 290 8 326 1130 1452 934 1175 1254 1546 843 738 923 1044 435 1111 88 169 661 907 941 901 974